Development of the combined immunotherapy using novel immunoregulatory cells for malignant pleural mesothelioma
Project/Area Number |
26861118
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Respiratory surgery
|
Research Institution | Kyushu University |
Principal Investigator |
|
Project Period (FY) |
2014-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2017: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2016: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 悪性腫瘍 / 薬物療法 / 免疫療法 / 悪性胸膜中皮腫 / 肺癌 / 呼吸器外科 / 腫瘍浸潤リンパ球 / 胸水 |
Outline of Final Research Achievements |
The purpose of the present study is to elucidate the impact of immune-regulatory cells (MDSC) in the pathogenesis of malignant pleural mesothelioma (MPM) and to demonstrate the possibility of novel immunotherapy for MPM using MDSC. By using an intrathoracic murine MPM model, we found that the number of MDSC increased in the pleural effusion after intrathoracic tumor cell injection. We also demonstrated that there are significant amount of MDSC in the pleural effusion of the MPM patient. In addition, we elucidated that c-reactive protein/albumin ratio which combines patient’s immune and nutritional status is a novel prognostic marker in MPM patients. These results suggest that novel immunotherapy targeting immuno-regulatory cells such as MDSC may be useful for MPM.
|
Report
(5 results)
Research Products
(3 results)
-
-
[Presentation] The C-reactive Protein/Albumin Ratio is a Novel Significant Prognostic factor in Patients with Malignant Pleural Mesothelioma2017
Author(s)
Takamori S., Toyokawa G., Tagawa T., Kinoshita F., Kozuma Y., Matsubara T., Haratake N., Akamine T., Hirai F., Takenoyama M, Ichinose Y., Maehara Y.
Organizer
18th World Conference on Lung Cancer
Related Report
Int'l Joint Research
-